SCINAI IMMUNOTHERAPEUTICS LTD. Other Operating Income (Expense), Net
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Other Operating Income (Expense), Net of $5.26 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherOperatingIncomeExpenseNet · last filed 2023-04-17
- SCINAI IMMUNOTHERAPEUTICS LTD. other operating income (expense), net for fiscal 2022 was $5.26M, a 98.23% increase from fiscal 2021.
- SCINAI IMMUNOTHERAPEUTICS LTD. other operating income (expense), net for fiscal 2021 was $2.66M.
| Period end | Other Operating Income (Expense), Net 12 month |
|---|---|
| 2022-12-31 | $5.26M 10-K · filed 2023-04-17 |
| 2021-12-31 | $2.66M 10-K · filed 2023-04-17 |